Merck KGaA Sees Return to Organic Sales Growth Next Year
By Adria Calatayud
Germany's Merck KGaA expects to return to organic sales growth next year after a broadly flat performance in 2023, helped by reduced Covid-19 headwinds and recovering demand for semiconductor materials.
The German life-sciences and electronics group said Thursday that it still expects organic sales for 2023 to range from a 2% fall to a 2% rise, resulting in net sales of between 20.5 billion and 21.9 billion euros ($21.60 billion-$23.08 billion).
In 2024, the decline in Covid-19-related sales in Merck's life-sciences segment will be smaller than in 2023, it said. Inventory reductions by key customers of the company's process-solutions segment should end early next year, paving the way for a pick-up in sales, Merck said.
The market for semiconductor materials is expected to recover incrementally in 2024, Merck said. Moreover, the company anticipates growth in its healthcare segment to normalize in line with medium-term aspirations.
Merck said its medium-term growth targets to 2025 remain unchanged, and that it expects to continue to grow beyond 2025.
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
October 19, 2023 02:35 ET (06:35 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
These Stocks Are (Still) Powering the Bull Market
-
5 Undervalued Energy Stocks to Play the AI Data Center Demand Boom
-
After Earnings, Is Lowe’s Stock a Buy, Sell, or Fairly Valued?
-
5 Stocks With the Largest Fair Value Estimate Cuts After Q1 Earnings
-
10 Stocks With the Largest Fair Value Estimate Increases After Q1 Earnings
-
Markets Brief: Inflation Back in the Spotlight
-
AI Is Booming, but Consumer Spending Is Slowing. Which Will Prevail in the Stock Market?
-
What’s Happening In the Markets This Week
-
3 Dividend Stocks for June 2024
-
After Earnings, Is Alibaba Stock a Buy, Sell, or Fairly Valued?
-
MongoDB Earnings: Slashing Valuation as Execution and Macro to Blame for Lower Guidance
-
Marvell Earnings: We Raise Our Medium-Term AI Forecast and Bring Our Valuation Up to $75
-
Zscaler Earnings: Impressive Traction in Emerging Products Drives Sales Growth for the Quarter
-
Dell Earnings: Raising Valuation on Strong AI, but the Stock Remains Severely Overvalued
-
After Earnings, Is Nvidia Stock a Buy, Sell, or Fairly Valued?
-
The 10 Best Companies to Invest in Now